Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-19

FDA Approved: PYRIDOSTIGMINE BROMIDE — Original Application (Acella Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for pyridostigmine bromide as a generic product developed by Acella Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

ORIG AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)